VEGFA and breast carcinoma: As indicated previously by Tang et al.[45], modulating CD147 expression and activity via recombinant DNA engineering and neutralizing antibodies influenced VEGF production at both the RNA and protein levels in human breast cancer cells in a CD147- and MMP-dependent fashion in cocultures of tumor cells and fibroblasts.